ZBNA
CAI

Zions Bancorporation, National Association’s Caris Life Sciences CAI Stock Holding History

Zions Bancorporation, National Association’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.5K Buy
2,384
+1,536
+181% +$27.5K ﹤0.01% 594
2026
Q1 		$15.2K Buy
+848
New +$18.5K ﹤0.01% 797

Other funds holding CAI

ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Zions Bancorporation, National Association's CAI Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its Caris Life Sciences (CAI) stake by 181% in Q2 2026, buying an estimated $27.5K and bringing the position to 2,384 shares worth $42.5K. The position accounts for ﹤0.01% of the portfolio, ranked #594.

Zions Bancorporation, National Association first reported a position in CAI in Q1 2026 and has held it in 2 quarters since. 50 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Zions Bancorporation, National Association held 2,384 shares of Caris Life Sciences worth $42.5K as of Q2 2026.
  • Zions Bancorporation, National Association bought 1,536 Caris Life Sciences shares in Q2 2026, an estimated $27.5K.
  • Caris Life Sciences made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #594 holding.
  • Zions Bancorporation, National Association first reported a position in Caris Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • 50 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.